Eli Lilly ROE - Return on Equity 2010-2024 | LLY

Eli Lilly return on equity for the quarter ending September 30, 2024 was 64.74.

  • Eli Lilly average return on equity for 2023 was 51.84, a 22.29% increase from 2022.
  • Eli Lilly average return on equity for 2022 was 66.71, a 27.41% decline from 2021.
  • Eli Lilly average return on equity for 2021 was 91.9, a 41.52% decline from 2020.

Roe - return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.

Eli Lilly ROE - Return on Equity 2010-2024 | LLY

  • Eli Lilly average return on equity for 2023 was 51.84, a 22.29% increase from 2022.
  • Eli Lilly average return on equity for 2022 was 66.71, a 27.41% decline from 2021.
  • Eli Lilly average return on equity for 2021 was 91.9, a 41.52% decline from 2020.

Roe - return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.